Study of stability of methotrexate in acidic solution spectrofluorimetric determination of methotrexate in pharmaceutical preparations through acid-catalyzed degradation reaction.
Study of the degradation reaction of methotrexate (MTX) in acidic solution was carried out. Optimization of the experimental parameters of MTX acid hydrolysis was investigated. Spectrofluorimetric method for determination of MTX through measurement of its acid-degradation product, 4-amino-4-deoxy-10-methylpteroic acid (AMP), was developed. Stability of the standard solution of MTX prepared in sulfuric acid was discussed in the view of accelerated stability analysis. Two other comparative spectroflourimetric methods based on measuring the fluorescence intensities from either a condensation reaction with acetylacetone-formaldehyde (Hantzsch reaction) or a reaction with fluorescamine were also described. Beer's law validation, accuracy, precision, limits of detection, limits of quantification, and other aspects of analytical merit are presented in the text. The proposed methods were successfully applied for the analysis of MTX in pure drug and tablets dosage form. The sensitivity of the developed methods was favorable, so it was possible to be adopted for determination of MTX in plasma samples for routine use in high-dose MTX therapy.
Sabry
Suzy M
SM
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt. suzymsabry@hotmail.com
Abdel-Hady
M
M
Elsayed
M
M
Fahmy
Osama T
OT
Maher
Hadir M
HM
D000143:Acids; D000964:Antimetabolites, Antineoplastic / Q000737:chemistry*; D002138:Calibration; D002384:Catalysis; D004355:Drug Stability; D005450:Fluorescamine / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007202:Indicators and Reagents; D007700:Kinetics; D008727:Methotrexate / Q000737:chemistry*; D012015:Reference Standards; D012996:Solutions; D013050:Spectrometry, Fluorescence; D013607:Tablets
D000143:Acids; D000964:Antimetabolites, Antineoplastic; D007202:Indicators and Reagents; D012996:Solutions; D013607:Tablets; D005450:Fluorescamine; D008727:Methotrexate